[1]
Dr. Tayyaba Zafar et al. 2025. Safety, Efficacy, and Tolerability of Tofacitinib in Children and Adolescents With Juvenile Idiopathic Arthritis in Pakistan. Journal of Health, Wellness and Community Research. 3, 6 (Jun. 2025), 1–11. DOI:https://doi.org/10.61919/2cpycr42.